Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-01-26
2009-10-06
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S130100, C424S150100, C424S164100, C424S184100, C424S185100, C424S200100, C530S300000, C530S350000, C536S023100, C536S023700
Reexamination Certificate
active
07597896
ABSTRACT:
The invention concernsMycobacteriumstrains whereof the erp gene is modified and a vaccine composition containing same. The modification of the erp gene decreases the virulence and the persistence of theMycobacteriumstrains.
REFERENCES:
patent: 5714593 (1998-02-01), Laqueyrerie et al.
patent: 6248581 (2001-06-01), Gicquel et al.
patent: WO 96/07745 (1996-03-01), None
patent: WO 96/23885 (1996-08-01), None
Noguchi, T., et al. “Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphat, and effect of ERP on cell growth.”, Molecular and Cellular Biology, (1993) vol. 13, No. 9, pp. 5195-5205.
Baldwin, S.L., et al, “Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis”, Infection and Immunity, vol. 66, No. 6, pp. 2951-2959, 1998.
Dhiman, N., et al, “Mycobacterial proteins—Immune targets for antituberculous subunit vaccine”, Indian journal of Experimental Biology, vol. 37, pp. 1157-1166, 1999.
Andersen, P., et al, “TB subunit vaccines—putting the pieces together”, Microbes and Infection, vol. 7, pp. 911-921, 2005.
Orme, I.M., et al, “Tuberculosis vaccine development: recent progress”, Trends in Microbiology, vol. 9, No. 3, pp. 115-118, 2001.
Collins, F.M., “New Generation Tuberculosis vaccines”, Clinical Microbiology Newsletter, vol. 23, No. 3, pp. 17-23, 2001.
Berthet at al. “Attenuation of Virulence by Disruption of theMycobacterium tuberculosis erpGene,” Science, Oct. 23, 1998, vol. 282, pp. 759-762.
F-X Berthet et al., “Characterization of theMycobacterium tuberculosis erpGene Encoding a Potential Cell Surface Protein with Repetitive Structures”, Microbiology, vol. 141, No. 9. pp. 2123-2130, (1995).
E.M. Lim et al., “Identification ofMycobacterium tuberculosisDNA Sequences Encloding Exported Proteins by UsingphoAGene Fusions”, Journal of Bacteriology, vol. 177, No. 1. pp. 59-65, (1995).
V. Pelicic et al., “Positive Selection of Allelic Exchange Mutants inMycobacterium bovisBCG”, FEMS Microbiology Letters, vol. 144, pp. 161-166, (1996).
V. Pelicic et al., “Efficient Allelic Exchange and Transposon Mutagenesis inMycobacterium tuberculosis” Proc. Natl. Acad. Sci., vol. 94, pp. 10955-10960, (1997).
Berthet François-Xavier
Gicquel Brigitte
Finnegan Henderson Farabow Garrett & Dunner LLP
Institut Pasteur
Swartz Rodney P.
LandOfFree
Composition comprising a protein encoded by a modified ERP... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising a protein encoded by a modified ERP..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising a protein encoded by a modified ERP... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078325